haki_whārangi

Ngā Pūrongo

He aha ngā mea me mōhio koe mō te palmitoylethanolamide (PEA)?

Ko te Palmitoylethanolamide (PEA) he amide waikawa ngako tūturu kua arohia mō ōna painga hauora pea. Kei roto i ngā kiko maha puta noa i te tinana tēnei matū, ā, e kī ana ngā rangahau ka taea e te palmitamideethanol (PEA) te whakaiti i te mumura, te whakaiti i te mamae, ā, ka taea hoki te whakatairanga i te hauora o te puku me te whakaroa i te koroheketanga. Tērā pea he maha ngā painga hauora. Ka tūhuratia e ngā tuhinga e whai ake nei ngā painga hauora o te palmitoylethanolamide (PEA), me pēhea tana mahi ki te tinana tangata, me pēhea te kimi i te palmitoylethanolamide (PEA) kounga teitei.

He aha te palmitoylethanolamide (PEA)?

Palmitoylethanolamide (PEA) he matū rite ki te endocannabinoid e kitea ana mō ōna āhuatanga whakamamae mamae me te ārai-mumura. Haunga te hanga e te tinana, ka kitea te PEA i roto i ngā momo kai tae atu ki: te tiihi, te toene hua manu, te mīti, te miraka, te pīnati, te lecithin soy.

I mōhio koe? Ina tūtaki te tinana ki ngā ahotea, pērā i te whara, te mumura rānei, ka whakarerekē ngā taumata PEA hei pupuri i te homeostasis pūtau.

He pēhea te pānga o te palmitoylethanolamide ki te tinana o te tangata?

Kāore anō kia tino mārama ngā kaipūtaiao ki te tikanga mahi a te palmitoylethanolamide. Ahakoa rā, kua roa te ara kua tae mai, nā te Ahorangi Rita Levi-Montalcini, nāna i whakamārama te tikanga mahi whānui o te palmitoylethanolamide i te tau 1992-1996. Mai i taua wā, kei te haere tonu tana rangahau i ngā pānga o te palmitoylethanolamide ki te mamae neuropathic me ngā mate pāwera.

E whā pea ngā painga nui o te Palmitoylethanolamide ki te hauora o te tangata:

●Whakamamae i te urupare mumura.

●Whakaitihia te whakahohenga o ngā pūtau mast (mate pāwera).

●Whakapakari i te mahi a te pūnaha hemp taketake.

●Whakahohe i ngā kaiwhakawhiwhi motuhake o te tinana.

He pēhea te whakamahinga a te PEA i ōna pānga ārai-mumura me te whakamamae i te mamae?

Ko ngā painga hauora o te PEA ko ngā pānga ki ngā pūtau ārai mate e whakahaere ana i te mumura, inā koa i roto i te roro. Tērā pea ka āwhina te PEA ki te whakaiti i te whakaputanga o ngā matū mumura. Heoi, ko te mahi nui a te PEA ki ngā kaiwhakawhiwhi i runga i ngā pūtau, e whakahaere ana i ngā āhuatanga maha o te mahi a te pūtau. Ka kiia ēnei kaiwhakawhiwhi ko ngā PPAR. Ka taea e te PEA me ētahi atu matū e āwhina ana ki te whakahohe i te PPAR te whakaiti i te mamae, ā, ka taea hoki te whakanui ake i te pākia o te tinana mā te tahu ngako, te whakaiti i ngā triglycerides toto, te whakanui ake i te cholesterol HDL toto, te whakapai ake i te whakahaere huka toto, me te āwhina i te whakaheke taumaha.

Ngā Painga o te Palmitoylethanolamide

Nā te mea he pānga mamae me te ārai-mumura tōna, e kī ana ngā rangahau ka āwhina pea te PEA i ngā momo mate mamae, pērā i te fibromyalgia, te sciatica, me te osteoarthritis.

1. Whakamamae i te mamae me te urupare mumura

He raruraru nui te mamae mau tonu e pāngia ana e ngā tūroro huri noa i te ao, ā, i te pakeketanga o te taupori, ka nui haere te kino o tēnei raruraru. Ko tētahi o ngā mahi a te palmitoylethanolamide he āwhina pea ki te whakamamae i te mamae me te mumura. Ka taunekeneke te palmitoylethanolamide me ngā kaiwhakawhiwhi CB1 me CB2, he wāhanga nui ēnei o te pūnaha hemp taketake. Ko tēnei pūnaha te kawenga mō te pupuri i te homeostasis, te taurite rānei i roto i te tinana.

Ina puta he whara, he mumura rānei, ka tukuna e te tinana ngā matū hemp taketake hei āwhina i te whakahaere i te urupare ārai mate. Tērā pea ka āwhina te palmitoylethanolamide ki te whakanui ake i ngā taumata hemp taketake i roto i te tinana, ā, mā reira ka whakamamae i te mamae me te mumura.

Hei tāpiritanga, ka taea e te palmitoylethanolamide te whakaiti i te tukunga o ngā matū mumura me te whakaiti i ngā urupare mumura whānui o te pūnaha io. Nā ēnei pānga ka waiho te palmitoylethanolamide hei taputapu pea hei āwhina i te whakahaere i te mamae me ngā urupare mumura. E whakaatu ana ngā rangahau he whai hua pea te palmitoylethanolamide mō te mamae sciatica me te carpal tunnel syndrome.

2. Te mate pukupuku o te uaua

He maha ngā rangahau e kī ana ka āwhina pea te PEA ki te whakaiti i ngā tohu o te fibromyalgia, he mate pūnaha io mau tonu e puta ai te mamae whānui. Ina whakamahia hei tāpiritanga ki ngā rongoā tuku iho, ka whakaitihia e te kai PEA te kaha o te mamae, ā, ka whakapai ake i te kounga o te oranga i roto i te wā. E ai ki tētahi rangahau, ko te tango i te PEA mō ngā marama e toru ka tino whakaiti i te mamae o te hunga whai fibromyalgia.

3. Mamae tuara

E tohu ana ngā rangahau tuatahi i te whai huatanga pea o te PEA mō te mamae o te tuara. I whakaatuhia e tētahi rangahau tirotiro i te tau 2017 i whakaitihia e te PEA te kaha o te mamae i roto i ngā tūroro i pāngia e te mate pokanga tuara i rahua.

Ko te hunga e pāngia ana e te sciatica, he mamae e toro atu ana i te tuara o raro ki raro i tētahi, i ngā waewae e rua rānei, ka kitea pea he whakamarie i muri i te tango i te PEA. I rangahauhia e tētahi whakamātautau matapōkere, matapo-rua, placebo-controlled ngā pānga o te PEA horopeta nui me te iti ki te placebo. I heke te mamae mā te neke atu i te 50% i roto i te rōpū horopeta nui. Ahakoa kāore i eke te PEA horopeta iti ki te taumata whakamarie mamae rite ki te horopeta nui, he nui ake te whai huatanga o ngā horopeta e rua i te placebo.

4. Te mate wheua me te wheua

Tērā pea he pai te PEA mō te hunga e pāngia ana e te osteoarthritis, he mate e tohuhia ana e te pirau o te kiriuhi hononga me te wheua. I kitea e ngā kaiuru i tētahi rangahau i whiwhi PEA he whakapainga nui i roto i ngā kaute Western Ontario me McMaster Universities Osteoarthritis Index (WOMAC) ki te whakaritea ki te rōpū placebo. Ko te WOMAC he pātai i hangaia hei aromatawai i te āhua me ngā tohu (hei tauira, te mamae, te pakari, te mahi tinana) i roto i ngā tūroro e pāngia ana e te osteoarthritis turi me te hope.

I roto i tētahi atu rangahau i uru atu ai ngā tūroro e pāngia ana e te mamae o te temporomandibular arthritic (TMJ) e pā ana ki te osteoarthritis, i whakaatuhia ko te tāpiringa PEA i whakapai ake i te kaha o te mamae i muri i ngā rā 14 ki te whakataurite ki te ibuprofen. Ko te rōpū i hoatuhia he PEA mō ngā rā 14 i whakaatu i te whakapainga nui ake i te whakatuwheratanga o te waha (he ine i te whakamamae mamae) i te rōpū ibuprofen.

5. Mamae neuropathic

E whakaatu ana ngā rangahau take tuatahi me ngā whakamātautau kararehe ka āwhina pea te PEA i te mamae neuropathic (nā te kino o ngā io e kawe ana i ngā karere i waenga i te roro me te taurakira), inā koa i roto i te hunga e pāngia ana e te mate carpal tunnel, te neuropathy mate huka, te chemotherapy. Ko te hunga e pāngia ana e te neuropathy peripheral, te mamae pelvic mau tonu, me te mamae e pā ana ki te whiu me te multiple sclerosis. Me whai atu ngā whakamātautau haumanu hei whakatau i te whai huatanga o te PEA ki te whakatau i te mamae neuropathic.

6. Te koroheketanga hauora

Ko te whakaroa i te tukanga koroheketanga he whāinga whai hua e whaia ana e te tini o ngā kaipūtaiao huri noa i te ao. E kiia ana ko te Palmitoylethanolamide he tāpiringa ārai-pakeketanga e āwhina ana ki te tiaki i ngā pūtau mai i te kino waikura, koinei te tino take o te koroheketanga.

Ina pāngia ngā pūtau e te nui rawa o ngā rauropi kore utu, ka puta pea ngā tauhohenga waikura, ka arahi ki te matenga o ngā pūtau i te wā o mua. Ko te kai i ngā kai kino, te momi hikareti, me ētahi atu pānga taiao pēnei i te parahanga o te hau ka whakanui ake i te kino waikura. Ka ārai pea te Palmitoylethanolamide i tēnei kino mā te tango i ngā rauropi kore utu me te whakaiti i te urupare mumura whānui i roto i te tinana.

Hei tāpiritanga, kua whakaaturia te kaha o te palmitoylethanolamide ethanol ki te whakaoho i te hanga o te collagen me ētahi atu pūmua kiri nui. Nō reira, ka whakaitihia pea te āhua o ngā kita me ngā raina angiangi, ka mahi hei tiaki i roto i ngā pūtau.

He kaihanga kua rēhitatia ki te FDA a Suzhou Myland Pharm & Nutrition Inc. e whakarato ana i te paura Palmitoylethanolamide (PEA) kounga teitei, parakore hoki.

I Suzhou Myland Pharm, e whakapau kaha ana mātou ki te whakarato i ngā hua kounga teitei rawa atu i ngā utu pai rawa atu. Kua whakamatautauria te parakore me te kaha o tā mātou paura Palmitoylethanolamide (PEA), kia whiwhi ai koe i tētahi tāpiringa kounga teitei ka taea e koe te whakawhirinaki. Ahakoa e hiahia ana koe ki te tautoko i te hauora pūtau, ki te whakapakari i tō pūnaha ārai mate, ki te whakarei ake rānei i te hauora whānui, ko tā mātou paura Palmitoylethanolamide (PEA) te whiringa tino pai.

Me te 30 tau o te wheako, me te mea hoki e ārahihia ana e te hangarau matatau me ngā rautaki R&D kua tino arotauhia, kua whakawhanakehia e Suzhou Myland Pharm he whānuitanga o ngā hua whakataetae, ā, kua riro hei kamupene auaha mō ngā tāpiringa pūtaiao koiora, te hanga ritenga me ngā ratonga hanga.

Hei tāpiritanga, he kaihanga kua rēhitatia ki te FDA a Suzhou Myland Pharm. He hou, he maha ngā mahi a ngā rauemi R&D a te kamupene, ngā whare whakaputa, me ngā taputapu tātari, ā, ka taea te whakaputa matū mai i te mirikaramu ki te tana i te tauine, me te tutuki i ngā paerewa ISO 9001 me ngā whakaritenga whakaputa GMP.

Whakakape: He kōrero whānui noa iho tēnei tuhinga, kaua e whakamāramatia he tohutohu hauora. Ko ētahi o ngā kōrero o te pou rangitaki i ahu mai i te Ipurangi, ehara i te mea ngaio. Ko tā tēnei paetukutuku anake he whakarōpū, he whakatakotoranga me te whakatika i ngā tuhinga. Ko te kaupapa o te kawe atu i ētahi atu kōrero, ehara i te mea e whakaae ana koe ki ōna tirohanga, e whakaū ana rānei i te pono o ōna ihirangi. Me kōrero tonu ki tētahi tohunga hauora i mua i te whakamahi i tētahi tāpiringa, i te hanga rānei i ngā huringa ki tō tikanga tiaki hauora.


Wā tuku: Hepetema-13-2024